These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 304178)

  • 21. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression of 'high affinity' T-cell rosettes indicative of recurrent carcinoma.
    Weese J; West W; Herberman R; Turcotte JG
    Surg Forum; 1977; 28():155-7. PubMed ID: 310169
    [No Abstract]   [Full Text] [Related]  

  • 23. Circulating human T cell subset with a reversible E-rossetting capacity in cancer and normals-hypothesis on the regulatory mechanism influencing their role in CMI.
    Moroz C; Kupfer B; Giler S
    Adv Exp Med Biol; 1979; 114():733-8. PubMed ID: 313689
    [No Abstract]   [Full Text] [Related]  

  • 24. Mutual relationship between total and active T lymphocytes in patients with malignant tumors.
    Babusíková O; Babusík P; Novotná L
    Neoplasma; 1978; 25(1):67-74. PubMed ID: 305544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ferritin in breast cancer].
    Góźdź S; Słuszniak J; Bukowski J; Zagała A; Kowalski D; Korejba W; Banasińska E; Cheba L
    Pol Tyg Lek; 1986 Sep; 41(35):1110-2. PubMed ID: 3797346
    [No Abstract]   [Full Text] [Related]  

  • 26. T acute lymphoblastic leukaemia with breast tumor. A brief report.
    Poros A; Hollán SR; Natonek K; Lelkes G; Gyódi E
    Haematologia (Budap); 1981; 14(2):215-8. PubMed ID: 6974118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of dose of thymosin for the in vitro induction of T-lymphocytes from patients with solid tumours.
    Byrom NA; Retsas S; Dean AJ; Hobbs JR
    Clin Oncol; 1978 Mar; 4(1):25-34. PubMed ID: 305835
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ferritin and breast cancer].
    Claustres M; Belaroussi N; Guilleux F; Magnan de Bornier B
    Pathol Biol (Paris); 1984 Apr; 32(4):265-8. PubMed ID: 6718068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between a serum factor and T lymphocytes in Gaucher disease.
    Bassan R; Montanelli A; Barbui T
    Am J Hematol; 1985 Apr; 18(4):381-4. PubMed ID: 3872064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Various immunological and immunomorphological changes in patients with breast cancer after interferon administration].
    Mkrtchian LN; Galstian AM; Ovanesbekova TG; Ter-Pogosian ZR; Kuznetsov VP
    Vopr Onkol; 1986; 32(10):25-31. PubMed ID: 3490716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum ferritin level in patients with breast cancer].
    Rusinowska Z; Rozek-Lesiak K; Kokocińska D
    Pol Tyg Lek; 1988 May; 43(22):706-8. PubMed ID: 3226979
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunological profile of patients with neoplastic disease].
    Stivala F; Catania G; Basile F; Malaponte G; Bottiglieri C; Giovinetto A
    Minerva Chir; 1981 Mar; 36(5):297-302. PubMed ID: 6972495
    [No Abstract]   [Full Text] [Related]  

  • 33. [Circulating immune complexes and immunologic reactivity in breast cancer].
    Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
    Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Functional activity of the regional lymph nodes in breast cancer patients].
    Loboda VI; Grinevich IuA
    Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E-rosette forming lymphocytes and serum immunoglobulins in breast cancer patients.
    Singh RP; Singh VP; Udupa KN
    Mater Med Pol; 1991; 23(3):179-81. PubMed ID: 1842710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of ferritin-bearing peripheral mononuclear blood cells in cancer patients by radioimmunoassay.
    Bluestein BI; Luderer AA; Hess D; Smith D; Meyer KK; Boyle G; Carter AC
    Cancer Res; 1984 Sep; 44(9):4131-6. PubMed ID: 6744324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of tumor marker assay in the staging of breast cancer. Assessment of ferritin and beta-HCG levels.
    Micali B; Gioffrè Florio MA; Venuti A; Giorgianni G; Saitta FP
    J Nucl Med Allied Sci; 1981; 25(3):65-70. PubMed ID: 7310528
    [No Abstract]   [Full Text] [Related]  

  • 38. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation versus immunity in early breast cancer.
    Turnbull AR; Turner DT; Jones BM; Wright R
    Clin Oncol; 1979 Sep; 5(3):237-44. PubMed ID: 315295
    [No Abstract]   [Full Text] [Related]  

  • 40. Spontaneous rosetting of human T lymphocytes with breast cancer cells.
    Kennett R; Seth R; Makgoba MW
    Int J Cancer; 1991 Sep; 49(2):317-9. PubMed ID: 1879975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.